IL1B and type 2 diabetes mellitus: It has beneficial antidiabetic effects on type 2 diabetic rats by affecting the AMPK-mediated signaling pathway in the pancreas by inhibiting the production of TNF-α, IL-6, caspase-3, IL-1, and apoptosis, and restoring pancreatic beta cells [64].